Related Experiment Videos

[Group B streptococci in neonatal pathology: pathogenetic mechanism, diagnosis and prevention]

Vestnik Akademii Meditsinskikh Nauk SSSR
|January 1, 1990
PubMed

Insights

Group B Streptococcus (GBS) causes neonatal disease, with increased vaginal epithelial sensitivity linked to contraceptives. Avirulent strains show higher adhesion, impacting mixed infections and neonatal outcomes.

Area of Science:

  • Microbiology
  • Neonatal Health
  • Epidemiology

Context:

  • Group B Streptococcus (GBS) is increasingly recognized as a significant cause of human neonatal disease.
  • Both vertical and horizontal transmission routes contribute to GBS infection spread.
  • Adults can be pathogen carriers, presenting diverse sources and transmission pathways.

Purpose:

  • To investigate the factors influencing Group B Streptococcus (GBS) adhesion to vaginal epithelium.
  • To explore the role of GBS strain virulence and host factors in neonatal infections.
  • To analyze the correlation between maternal GBS serotypes and neonatal outcomes.

Summary:

  • Increased vaginal epithelial sensitivity to GBS adhesion was observed with certain contraceptive use.
  • Avirulent GBS strains exhibited higher adhesive activity than virulent strains, particularly relevant in viral-bacterial co-infections.
  • A study isolated over 80 GBS strains (serotypes Ia/C, Ib/C, II/C, III/R) between 1985-1987, with only 54% of GBS-carrying pregnancies resulting in favorable neonatal outcomes.
  • Maternal isolate and abortus strain serotypes showed complete correlation.

Impact:

  • Findings highlight the complex interplay between GBS, host factors (e.g., contraceptive use), and viral infections in disease pathogenesis.
  • The study underscores the need for improved laboratory diagnostics and identification methods for GBS and its carriers.
  • Results emphasize the significant risk of adverse neonatal outcomes associated with GBS carriage during pregnancy.

Related Concept Videos